23:12 , Jun 11, 2018 |  BC Extra  |  Preclinical News

Summit identifies two new classes of antibiotics

Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) identified two new types of narrow-spectrum antibiotics targeting new Neisseria gonorrhoeae targets that could help treat gonorrhea. Summit presented its findings at the American Society for Microbiology Microbe (ASM Microbe) conference...